====== Olaparib 4μM R08 exp512 ====== ==== Mechanism of Action ==== Inhibits PARP1 and PARP2, blocks ssDNA break repair, selectively toxic to BRCA1/2 negative cancers * **Class / Subclass 1:** DNA Damage, Repair and Replication / PARP Inhibitor ==== Technical Notes ==== * **PubChem Name:** %%Olaparib%% * **Synonyms:** AZD2281; KU0059436 * **CAS #:** 763113-22-0 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/23725625|23725625]] * **IUPAC:** %%4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one%% * **INCHI Name:** InChI=1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30) * **INCHI Key:** FDLYAMZZIXQODN-UHFFFAOYSA-N * **Molecular Weight:** 434.5 * **Canonical SMILES:** C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F * **Isomeric SMILES:** N/A * **Molecular Formula:** C24H23FN4O3 {{:chemogenomics:structures:chem-0317.svg?nolink}} * **Supplier Name:** Med Chem Express * **Catalog #:** HY-10162 * **Lot #:** 24830 * **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C24H23FN4O3 435.1827; found 435.18457 * **Platform ID:** Olaparib * **Min:** -6.7026; **Max:** 94.1282 {{:chemogenomics:dose_response:dr_566.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |2.5010 | | IC20 |3.3100 | | IC30 |3.9880 | | IC40 |4.6460 | | IC50 |5.3450 | | IC60 |6.1490 | | IC70 |7.1640 | | IC80 |8.6310 | | IC90 |11.4200 | \\ ==== Screen Summary ==== * **Round**: 08 * **Dose**: 4µM * **Days of incubation**: 8 * **Doublings**: 2.2 * **Numbers of reads**: 17298761 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |42/114|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Olaparib_4uM_Round-8_exp512.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp512.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:M:MCM9|MCM9]]|-4.83|0.00| |[[:human_genes:P:PRDX1|PRDX1]]|-4.38|0.00| |[[:human_genes:D:DNPH1|DNPH1]]|-3.97|0.00| |[[:human_genes:S:SWSAP1|SWSAP1]]|-3.85|0.00| |[[:human_genes:S:SMARCAL1|SMARCAL1]]|-3.83|0.00| |[[:human_genes:A:APITD1|APITD1]]|-3.70|0.00| |[[:human_genes:G:GTPBP2|GTPBP2]]|-3.65|0.00| |[[:human_genes:P:POLB|POLB]]|-3.55|0.00| |[[:human_genes:A:APITD1-CORT|APITD1-CORT]]|-3.48|0.00| |[[:human_genes:U:UBE2N|UBE2N]]|-3.30|0.00| |[[:human_genes:Z:ZBTB1|ZBTB1]]|-3.28|0.00| |[[:human_genes:R:RAD54L|RAD54L]]|-3.24|0.00| |[[:human_genes:H:HELLS|HELLS]]|-3.22|0.00| |[[:human_genes:Z:ZSWIM7|ZSWIM7]]|-3.16|0.00| |[[:human_genes:K:KPNA3|KPNA3]]|-3.13|<0.01| |[[:human_genes:S:SIVA1|SIVA1]]|-3.03|<0.01| |[[:human_genes:M:MDM2|MDM2]]|-3.03|<0.01| |[[:human_genes:Y:YPEL5|YPEL5]]|-2.99|<0.01| |[[:human_genes:H:HELQ|HELQ]]|-2.98|<0.01| |[[:human_genes:V:VPS25|VPS25]]|-2.82|0.13| |[[:human_genes:N:NFRKB|NFRKB]]|-2.73|<0.01| |[[:human_genes:K:KPNA4|KPNA4]]|-2.68|<0.01| |[[:human_genes:C:C1orf112|C1orf112]]|-2.67|<0.01| |[[:human_genes:R:RNF168|RNF168]]|-2.67|<0.01| |[[:human_genes:S:SPIDR|SPIDR]]|-2.67|<0.01| |[[:human_genes:L:LIG3|LIG3]]|-2.66|0.01| |[[:human_genes:I:ITPA|ITPA]]|-2.54|0.01| |[[:human_genes:U:USP7|USP7]]|-2.54|0.02| |[[:human_genes:S:STRA13|STRA13]]|-2.50|0.01| |[[:human_genes:R:RNASEH2A|RNASEH2A]]|-2.49|0.05| |[[:human_genes:C:CASP9|CASP9]]|3.35|0.00| |[[:human_genes:C:CYCS|CYCS]]|3.36|0.00| |[[:human_genes:P:PLAA|PLAA]]|3.41|0.00| |[[:human_genes:A:ALAS1|ALAS1]]|3.42|<0.01| |[[:human_genes:T:TFDP1|TFDP1]]|3.48|0.00| |[[:human_genes:F:FAF2|FAF2]]|3.48|0.00| |[[:human_genes:G:GCN1L1|GCN1L1]]|3.48|0.00| |[[:human_genes:S:SLC20A1|SLC20A1]]|3.50|0.00| |[[:human_genes:R:RPS25|RPS25]]|3.55|0.00| |[[:human_genes:E:ENY2|ENY2]]|3.56|0.00| |[[:human_genes:E:EIF4A1|EIF4A1]]|3.57|0.00| |[[:human_genes:T:TRMT10A|TRMT10A]]|3.62|0.00| |[[:human_genes:N:NSUN2|NSUN2]]|3.65|0.00| |[[:human_genes:Z:ZCCHC8|ZCCHC8]]|3.71|0.00| |[[:human_genes:V:VDAC2|VDAC2]]|3.82|0.00| |[[:human_genes:D:DIABLO|DIABLO]]|3.88|0.00| |[[:human_genes:R:RICTOR|RICTOR]]|3.98|0.00| |[[:human_genes:M:MLST8|MLST8]]|4.02|0.00| |[[:human_genes:P:PMAIP1|PMAIP1]]|4.26|0.00| |[[:human_genes:I:IRF2|IRF2]]|4.28|0.00| |[[:human_genes:P:PARP2|PARP2]]|4.53|0.00| |[[:human_genes:M:MAPKAP1|MAPKAP1]]|4.53|0.00| |[[:human_genes:A:AHCYL1|AHCYL1]]|4.60|0.00| |[[:human_genes:A:APAF1|APAF1]]|4.97|0.00| |[[:human_genes:M:MARCH5|MARCH5]]|5.41|0.00| |[[:human_genes:A:ADPRHL2|ADPRHL2]]|5.99|0.00| |[[:human_genes:B:BAK1|BAK1]]|6.55|0.00| |[[:human_genes:S:SLFN11|SLFN11]]|6.79|0.00| |[[:human_genes:T:TP53|TP53]]|7.12|0.00| |[[:human_genes:P:PARP1|PARP1]]|7.76|0.00| ^Screen^Correlation^Plot^ |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|0.204|| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|0.088|| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|0.086|| |[[:results:exp443|SNS-032 15μM R08 exp443]]|0.083|| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|0.082|| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|0.079|| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|0.077|| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|0.075|| |[[:results:exp531|THZ1 0.06μM R08 exp531]]|0.074|| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|0.072|| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|0.069|| |[[:results:exp517|Quercetin 20μM R08 exp517]]|0.067|| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|0.064|| |[[:results:exp85|UM0129480 7μM R02 exp85]]|0.063|| |[[:results:exp515|PU-H71 1μM R08 exp515]]|0.059|| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|0.058|| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|0.057|| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|0.055|| |[[:results:exp34|Rotenone 20μM R00 exp34]]|0.055|| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|0.16|| |[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|0.121|| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|0.117|| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|0.116|| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|0.115|| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|0.113|| |[[:results:exp135|MS023 7μM R03 exp135]]|0.105|| |[[:results:exp211|AICAR 240μM R05 exp211]]|0.104|| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|0.093|| |[[:results:exp485|GSK626616 14μM R08 exp485]]|0.092|| |[[:results:exp116|AICAR 240μM R03 exp116]]|0.091|| |[[:results:exp459|Bleomycin 5μM R08 exp459]]|0.09|| |[[:results:exp134|MS023 2μM R03 exp134]]|0.09|| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|0.086|| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|0.081|| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|0.078|| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|0.076|| |[[:results:exp474|CR131-b 0.005μM R08 exp474]]|0.076|| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|0.076|| |[[:results:exp199|Etoposide 0.3μM R05 exp199]]|0.075|| |[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|0.073|| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|0.073|| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|0.072|| |[[:results:exp472|CI-1040 9.5μM R08 exp472]]|0.07|| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|0.07|| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|0.069|| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|0.066|| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|0.066|| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|0.065|| |[[:results:exp198|Etoposide 0.1μM R05 exp198]]|0.064|| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|0.062|| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|0.061|| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|0.06|| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|0.06|| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|0.057|| |[[:results:exp19|Etoposide 1μM R00 exp19]]|0.057|| |[[:results:exp270|Campthothecin 0.001μM R06 exp270]]|0.056|| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|0.056|| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|0.055|| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|0.055|| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|0.054|| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|0.052|| {{:chemogenomics:comparison_plots:exp512_vs_exp520.png?nolink |}} {{:chemogenomics:comparison_plots:exp299_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp512_vs_exp529.png?nolink |}} {{:chemogenomics:comparison_plots:exp443_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp512_vs_exp535.png?nolink |}} {{:chemogenomics:comparison_plots:exp512_vs_exp525.png?nolink |}} {{:chemogenomics:comparison_plots:exp512_vs_exp80.png?nolink |}} {{:chemogenomics:comparison_plots:exp512_vs_exp78.png?nolink |}} {{:chemogenomics:comparison_plots:exp512_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp512_vs_exp524.png?nolink |}} {{:chemogenomics:comparison_plots:exp28_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp512_vs_exp517.png?nolink |}} {{:chemogenomics:comparison_plots:exp512_vs_exp526.png?nolink |}} {{:chemogenomics:comparison_plots:exp512_vs_exp85.png?nolink |}} {{:chemogenomics:comparison_plots:exp512_vs_exp515.png?nolink |}} {{:chemogenomics:comparison_plots:exp36_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp240_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp147_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp34_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp440_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp503_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp489_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp354_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp488_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp456_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp135_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp211_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp234_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp485_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp116_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp459_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp134_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp2_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp3_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp294_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp478_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp474_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp355_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp199_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp259_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp329_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp374_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp472_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp435_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp357_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp349_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp450_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp214_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp198_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp21_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp505_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp468_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp512_vs_exp6.png?nolink |}} {{:chemogenomics:comparison_plots:exp335_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp19_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp270_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp175_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp512_vs_exp75.png?nolink |}} {{:chemogenomics:comparison_plots:exp497_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp498_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp441_vs_exp512.png?nolink |}} ^GO Term^Fold Change^Genes^ |interstrand cross-link repair|72.20|MCM9,CENPS,RNF168,CENPX| |double-strand break repair via nonhomologous end joining|58.44|SMARCAL1,POLB,HELQ,RNF168| |DNA-templated DNA replication maintenance of fidelity|46.31|MCM9,SMARCAL1,CENPS,CENPX| |recombinational repair|41.25|MCM9,SWSAP1,UBE2N,RAD54L,ZSWIM7,HELQ,SPIDR,LIG3| |double-strand break repair via homologous recombination|37.03|MCM9,UBE2N,RAD54L,ZSWIM7,HELQ,SPIDR,LIG3| |DNA recombination|35.77|MCM9,SWSAP1,CENPS,POLB,UBE2N,RAD54L,ZSWIM7,HELQ,NFRKB,RNF168,SPIDR,LIG3,CENPX| |double-strand break repair|33.58|MCM9,SWSAP1,SMARCAL1,POLB,UBE2N,RAD54L,ZSWIM7,HELQ,RNF168,SPIDR,LIG3| |DNA-templated DNA replication|28.32|MCM9,SMARCAL1,CENPS,POLB,LIG3,CENPX| |ATP-dependent activity, acting on DNA|26.92|MCM9,SMARCAL1,RAD54L,HELLS,HELQ| |positive regulation of DNA repair|25.36|UBE2N,HELQ,NFRKB,RNF168,SPIDR| |response to ionizing radiation|23.24|POLB,RAD54L,MDM2,RNF168,SPIDR| |DNA repair|20.94|MCM9,SWSAP1,SMARCAL1,CENPS,POLB,UBE2N,ZBTB1,RAD54L,ZSWIM7,HELQ,NFRKB,RNF168,SPIDR,LIG3,USP7,CENPX| |helicase activity|20.59|MCM9,SMARCAL1,RAD54L,HELLS,HELQ| |DNA replication|19.08|MCM9,SMARCAL1,CENPS,POLB,LIG3,CENPX| |catalytic activity, acting on DNA|18.28|MCM9,SMARCAL1,POLB,RAD54L,HELLS,HELQ,LIG3| |DNA damage response|14.65|MCM9,SWSAP1,SMARCAL1,CENPS,POLB,UBE2N,ZBTB1,RAD54L,ZSWIM7,MDM2,HELQ,NFRKB,RNF168,SPIDR,LIG3,USP7,CENPX| |DNA metabolic process|14.61|MCM9,SWSAP1,SMARCAL1,CENPS,POLB,UBE2N,ZBTB1,RAD54L,HELLS,ZSWIM7,HELQ,NFRKB,RNF168,SPIDR,LIG3,USP7,CENPX| |positive regulation of DNA metabolic process|12.92|UBE2N,HELQ,NFRKB,RNF168,SPIDR,USP7| |chromosome organization|9.76|MCM9,SMARCAL1,RAD54L,HELQ,NFRKB,ITPA,CENPX| ^GO Term^Fold Change^Genes^ |apoptosome|552.30|APAF1,CASP9| |NAD DNA ADP-ribosyltransferase activity|552.30|PARP1,PARP2| |activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c|441.84|APAF1,DIABLO,CYCS,CASP9| |TORC2 complex|207.11|MAPKAP1,MLST8,RICTOR| |regulation of mitochondrial membrane permeability|40.17|TP53,BAK1,PMAIP1,VDAC2| |apoptotic mitochondrial changes|39.45|TP53,BAK1,PMAIP1,VDAC2| |neuron apoptotic process|27.34|TP53,APAF1,PARP2,DIABLO,CASP9| |positive regulation of cysteine-type endopeptidase activity|26.94|BAK1,APAF1,PMAIP1,DIABLO,CYCS,CASP9| |positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|26.30|APAF1,PMAIP1,DIABLO,CYCS,CASP9| |site of DNA damage|25.57|PARP1,TP53,SLFN11,ADPRS,PARP2| |intrinsic apoptotic signaling pathway|24.16|TP53,BAK1,APAF1,PMAIP1,DIABLO,CYCS,CASP9| |positive regulation of endopeptidase activity|23.01|BAK1,APAF1,PMAIP1,DIABLO,CYCS,CASP9| |positive regulation of peptidase activity|20.97|BAK1,APAF1,PMAIP1,DIABLO,CYCS,CASP9| |regulation of cysteine-type endopeptidase activity|17.72|BAK1,APAF1,PMAIP1,DIABLO,CYCS,CASP9| |apoptotic signaling pathway|16.14|TP53,BAK1,APAF1,PARP2,PMAIP1,DIABLO,VDAC2,CYCS,CASP9| |cellular response to external stimulus|11.82|TP53,BAK1,MAPKAP1,PMAIP1,MLST8,RICTOR,GCN1| |response to nutrient levels|9.34|TP53,APAF1,MAPKAP1,PARP2,PMAIP1,MLST8,RICTOR,GCN1| |response to extracellular stimulus|8.80|TP53,APAF1,MAPKAP1,PARP2,PMAIP1,MLST8,RICTOR,GCN1| |DNA damage response|6.98|PARP1,TP53,SLFN11,BAK1,ADPRS,PARP2,PMAIP1,MLST8,CASP9|